274 related articles for article (PubMed ID: 24189185)
1. Role of aldo-keto reductase family 1 (AKR1) enzymes in human steroid metabolism.
Rižner TL; Penning TM
Steroids; 2014 Jan; 79():49-63. PubMed ID: 24189185
[TBL] [Abstract][Full Text] [Related]
2. Steroid 5β-reductase (AKR1D1): Purification and characterization.
Penning TM
Methods Enzymol; 2023; 689():277-301. PubMed ID: 37802574
[TBL] [Abstract][Full Text] [Related]
3. Steroid hormone transforming aldo-keto reductases and cancer.
Penning TM; Byrns MC
Ann N Y Acad Sci; 2009 Feb; 1155():33-42. PubMed ID: 19250190
[TBL] [Abstract][Full Text] [Related]
4. Aldo-Keto Reductase AKR1C1-AKR1C4: Functions, Regulation, and Intervention for Anti-cancer Therapy.
Zeng CM; Chang LL; Ying MD; Cao J; He QJ; Zhu H; Yang B
Front Pharmacol; 2017; 8():119. PubMed ID: 28352233
[TBL] [Abstract][Full Text] [Related]
5. Relevance of Human Aldoketoreductases and Microbial
Basit A; Amory JK; Mettu VS; Li CY; Heyward S; Jariwala PB; Redinbo MR; Prasad B
Drug Metab Dispos; 2023 Apr; 51(4):427-435. PubMed ID: 36623880
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Behavioral Effects of GABAergic Low- and High-Efficacy Neuroactive Steroids in the Zebrafish Larvae Assay.
Germann AL; Xu Y; Covey DF; Evers AS; Akk G
ACS Chem Neurosci; 2024 Mar; 15(5):909-915. PubMed ID: 38386612
[TBL] [Abstract][Full Text] [Related]
7. The gut microbiome: an orchestrator of xenobiotic metabolism.
Collins SL; Patterson AD
Acta Pharm Sin B; 2020 Jan; 10(1):19-32. PubMed ID: 31998605
[TBL] [Abstract][Full Text] [Related]
8. Aldo-keto reductase 1C2 (AKR1C2) as the second gene associated to non-syndromic primary lipedema: investigating activating mutation or overexpression as causative factors.
Kaftalli J; Donato K; Bonetti G; Dhuli K; Macchia A; Maltese PE; Louise Herbst K; Michelini S; Chiurazzi P; Hill M; Michelini S; Michelini S; Marceddu G; Bernini A; Bertelli M
Eur Rev Med Pharmacol Sci; 2023 Dec; 27(6 Suppl):127-136. PubMed ID: 38112953
[TBL] [Abstract][Full Text] [Related]
9. The SDR (short-chain dehydrogenase/reductase and related enzymes) nomenclature initiative.
Persson B; Kallberg Y; Bray JE; Bruford E; Dellaporta SL; Favia AD; Duarte RG; Jörnvall H; Kavanagh KL; Kedishvili N; Kisiela M; Maser E; Mindnich R; Orchard S; Penning TM; Thornton JM; Adamski J; Oppermann U
Chem Biol Interact; 2009 Mar; 178(1-3):94-8. PubMed ID: 19027726
[TBL] [Abstract][Full Text] [Related]
10. The aldo-keto reductases (AKRs): Overview.
Penning TM
Chem Biol Interact; 2015 Jun; 234():236-46. PubMed ID: 25304492
[TBL] [Abstract][Full Text] [Related]
11. Long-chain fatty acids inhibit human members of the aldo-keto reductase 1C subfamily.
Hara A; Endo S; Matsunaga T; Soda M; Yashiro K; El-Kabbani O
J Biochem; 2017 Nov; 162(5):371-379. PubMed ID: 28992312
[TBL] [Abstract][Full Text] [Related]
12. Aldo-Keto Reductase (AKR) 1C3 inhibitors: a patent review.
Penning TM
Expert Opin Ther Pat; 2017 Dec; 27(12):1329-1340. PubMed ID: 28895472
[TBL] [Abstract][Full Text] [Related]
13. Testosterone treatment increases androgen receptor and aromatase gene expression in myotubes from patients with PCOS and controls, but does not induce insulin resistance.
Eriksen MB; Glintborg D; Nielsen MF; Jakobsen MA; Brusgaard K; Tan Q; Gaster M
Biochem Biophys Res Commun; 2014 Sep; 451(4):622-6. PubMed ID: 25130462
[TBL] [Abstract][Full Text] [Related]
14. Rate of steroid double-bond reduction catalysed by the human steroid 5β-reductase (AKR1D1) is sensitive to steroid structure: implications for steroid metabolism and bile acid synthesis.
Jin Y; Chen M; Penning TM
Biochem J; 2014 Aug; 462(1):163-71. PubMed ID: 24894951
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of arachidonic acid metabolites change during prostate cancer progression.
Rodríguez-Blanco G; Burgers PC; Dekker LJ; Ijzermans JJ; Wildhagen MF; Schenk-Braat EA; Bangma CH; Jenster G; Luider TM
Prostate; 2014 May; 74(6):618-27. PubMed ID: 24435810
[TBL] [Abstract][Full Text] [Related]
16. Promiscuity and diversity in 3-ketosteroid reductases.
Penning TM; Chen M; Jin Y
J Steroid Biochem Mol Biol; 2015 Jul; 151():93-101. PubMed ID: 25500069
[TBL] [Abstract][Full Text] [Related]
17. Oxidative and reductive metabolism of lipid-peroxidation derived carbonyls.
Singh M; Kapoor A; Bhatnagar A
Chem Biol Interact; 2015 Jun; 234():261-73. PubMed ID: 25559856
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal.
Schmitt J; Kong B; Stieger B; Tschopp O; Schultze SM; Rau M; Weber A; Müllhaupt B; Guo GL; Geier A
Liver Int; 2015 Apr; 35(4):1133-1144. PubMed ID: 25156247
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation of the intestinal nuclear bile acid farnesoid X receptor (FXR) by the caudal-related homeobox 2 (CDX2).
Modica S; Cariello M; Morgano A; Gross I; Vegliante MC; Murzilli S; Salvatore L; Freund JN; Sabbà C; Moschetta A
J Biol Chem; 2014 Oct; 289(41):28421-32. PubMed ID: 25138215
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
